Assessment of troponin I level in patients with acute myocardial infarction and its impact on clinical outcome: An observational study

Govind Koureti; Ashish Kumar Jain; Parul Jain; Anubhuti Jain; Madhvika Patidar; Prerna Raje Batham

doi:10.53730/ijhs.v6nS6.10609

Authors

Govind Koureti Post – Graduate student, Department of Medicine, MGM Medical college and MY Hospital, Indore
Ashish Kumar Jain Professor, Department of Cardiology, MGM Medical college and MY Hospital, Indore
Parul Jain
paruljain191919@gmail.com
Assistant Professor, Department of Periodontology, Government College of Dentistry, Indore
Anubhuti Jain Assistant Professor, Department of Obstetrics and Gynecology, Geetanjali medical college and hospital, Udaipur
Madhvika Patidar Assistant Professor, Department of Oral Pathology and Microbiology, Government College of Dentistry
Prerna Raje Batham Assistant Professor, Department of Orthodontics and dentofacial Orthopedics, Government College of Dentistry, Indore

Keywords:

cardiac troponin- I level, heart failure, cardiac mortality, acute myocardial infarction, coronary artery disease

Abstract

Introduction: Coronary Artery disease is one of the major causes of Mortatlity I the world that included Myocardial ischemia and infarction. Cardiac toponins are (troponin- I and Troponin -T) the markers of myocardial ischemia and they are the sign of Myocardial damage. They can provide important diagnostic and prognostic information. Aim : In the present study the correlation of clinical presentation, complication and outcome with reference of different level (mild, moderate and severe) of elevated troponin enzyme level was studied. Material and method: 100 patientspresented with acute myocardial infarct ion were studied for clinical presentation (hemodynamics, heart failure, mechanical complication, angina, shock) and ICCU stay and total hospital stay, recurrent angina, heart failure, re-infarct, morbidity and mortality was recorded. Their cardiac troponin- I level was measured and corelated accordingly in group 1 (mild elevation: cTnIlevel baseline (0.004) totentimes), group 2 (moderate elevation: cTnIlevel ten times to hundredtimes) and group 3 (severe elevation: cTnIlevel morethan hundredtimes). RESULTS: Significantly greater number of patients with recurrent angina were having severely elevated Troponin-I level. Relocation of patient in ICCU was more with patient with severely elevated level. Severity of cardiac failure and Troponin-I levels were found to be significantly associated with each other.

Downloads

Download data is not yet available.

References

Ralapanawa U, Sivakanesan R. Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review. J Epidemiol Glob Health. 2021;11(2):169-177. doi:10.2991/jegh.k.201217.001

Krishnan MN. Coronary heart disease and risk factors in India - on the brink of an epidemic?. Indian Heart J. 2012;64(4):364-367. doi:10.1016/j.ihj.2012.07.001

Sreeniwas Kumar A, Sinha N. Cardiovascular disease in India: A 360 degree overview. Med J Armed Forces India. 2020;76(1):1-3. doi:10.1016/j.mjafi.2019.12.005.

Braun MM, Stevens WA, Barstow CH. Stable Coronary Artery Disease: Treatment. Am Fam Physician. 2018 Mar 15;97(6):376-384. PMID: 29671538.

DeshpandeS,LokhandwalaY.DeshpandeS,etal. APIexpertconsensusdocumentonmanagementofischemicheartdisease.JAssoc Physicians India. 2006 Sep;54:748; author reply 748-50. J Assoc Physicians India. 2006.

Tahann AS et al. High sensitivity Troponin I levels and coronary artery disease severity, progression, and long term outcomes. Journal of the American Heart Association. 2018;7:e007914.

DaněkJ et al. Troponin levels in patients with stable CAD. Cor et Vasa 2017;59(3): e229-e234.

Jaffe AS and Vasile VC. Using cardiac Troponin in the diagnosis and management of patients with putatively stable Ischemic Heart Diseases. American College of Cardiology. 2016.https://www.acc.org/latest-in-cardiology/articles/2016/02/26/09/34/

Bhandari M, Singh V and Venkatraman D. A study of risk factors for acute myocardial infarction in patients below 35 years in eastern India. Nig J Cardiol 2007;14:84-91.

Bhardwaj R, Kandoria A, Sharma R. Myocardial infarction in young adults-risk factors and pattern of coronary artery involvement. Niger Med J. 2014;55(1):44-47. doi:10.4103/0300-1652.128161.

Srivastava RK et al. Gender risk profile in acute myocardial infarction- A prospective study in Indian population. International Journal of Scientific and Research Publications 2014;4(3):1-3.

Gaur M. Tobacco use in India: An epidemic of smoking, chewing and snuffing. International Journal of Scientific & Engineering Research Volume 2017;8(5):1808-1810.

Stark M, Kerndt CC, Sharma S. Troponin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.

El-Menyar A, Zubaid M, AlMahmeed W, Sulaiman K, AlNabti A, Singh R, Al Suwaidi J. Killip classification in patients with acute coronary syndrome: insight from a multicenter registry. Am J Emerg Med. 2012 Jan;30(1):97-103.

Sun JC and Joffe HV. Unstable Angina and Non‐ST Elevation Myocardial Infarction. In: The Most Common Inpatient Problems in Internal Medicine. W.B. Saunders. 2007. Pages 51-81.

Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202

Mukhtar, A. U. S., Budu, B., Sanusi B, Y., Mappawere, N. A., & Azniah, A. (2022). The effect of reproductive health education with multimedia video learning on the improvement of fluor albus prevention behavior young woman pathologist. International Journal of Health & Medical Sciences, 5(1), 75-79. https://doi.org/10.21744/ijhms.v5n1.1841